I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
TREND statement checklist:
Ian R. Woodcock
;
George Tachas
;
Nuket Desem
...
doi:10.1371/journal.pone.0294847.s001. , 2024
Link:
https://doi.org/10.1371/journal.pone.0294847.s001
RT Journal T1
TREND statement checklist
UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_25064356&Exemplar=1&LAN=DE A1 Ian R. Woodcock A1 George Tachas A1 Nuket Desem A1 Peter J. Houweling A1 Michael Kean A1 Jaiman Emmanuel A1 Rachel Kennedy A1 Kate Carroll A1 Katy de Valle A1 Justine Adams A1 Shireen R. Lamandé A1 Chantal Coles A1 Chrystal Tiong A1 Matthew Burton A1 Daniella Villano A1 Peter Button A1 Jean-Yves Hogrel A1 Sarah Catling-Seyffer A1 Monique M. Ryan A1 Martin B. Delatycki A1 Eppie M. Yiu YR 2024 K1 Biochemistry K1 Medicine K1 Cell Biology K1 Genetics K1 Pharmacology K1 Biotechnology K1 Immunology K1 Developmental Biology K1 Cancer K1 Infectious Diseases K1 Virology K1 upper limb test K1 upper limb function K1 statistically significantly higher K1 statistically significant change K1 serious adverse events K1 secondary objectives included K1 novel antisense drug K1 mri fat fraction K1 exacerbating muscle damage K1 contraction induced injury K1 apparent stabilisation observed K1 phase 2 open K1 2 &# 8217 K1 injection site erythema K1 functional muscle strength K1 four weeks past K1 25 mg weekly K1 high cd49d expressing K1 cd49d alpha subunit K1 study duration support K1 mean change 0 K1 week 28 compared K1 xlink "> atl1102 K1 xlink "> K1 pul 2 K1 weekly dosing K1 subcutaneous injection K1 myopinch compared K1 functional changes K1 week 8 K1 24 weeks K1 well tolerated K1 week 24 K1 stable throughout K1 stable dose K1 skin discoloration K1 reducing survival K1 progressive weakess K1 pinch measures JF doi:10.1371/journal.pone.0294847.s001 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0294847.s001 DO https://doi.org/10.1371/journal.pone.0294847.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)